Trigeminal Nerve Involvement in Bulbar-Onset Anti-IgLON5 Disease-Reference-Cited by-同舟云学术

Trigeminal Nerve Involvement in Bulbar-Onset Anti-IgLON5 Disease

Published:2023-11 Issue:6 Volume:10 Page:
ISSN:2332-7812
Container-title:Neurology Neuroimmunology & Neuroinflammation
language:en
Short-container-title:Neurol Neuroimmunol Neuroinflamm

Author:

Cluse Florent¹^ORCID,Hermier Marc¹,Demarquay Genevieve¹,Rogemond Veronique¹^ORCID,Mallaret Martial¹,Svahn Juliette¹,Pegat Antoine¹^ORCID,Honnorat Jerome¹,Bernard Emilien¹^ORCID

Affiliation:

1. From the ALS Resource and Competence Center (F.C., J.S., A.P., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Electroneuromyography and Neuromuscular Diseases Unit (F.C.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Department of Neuroradiology (M.H.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Neurophysiology & Epilepsy Unit (G.D.), Neurological Hospital P. Wertheimer, Hospices Civils de Lyon; Reference Centre for Paraneoplastic Neurological Syndromes and...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Neurology

Link

https://www.neurology.org/doi/pdfdirect/10.1212/NXI.0000000000200153

Reference15 articles.

1. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study

2. Clinical manifestations of the anti-IgLON5 disease

3. Neuropathological criteria of anti-IgLON5-related tauopathy

4. Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome

5. Expanding the clinical spectrum of anti‐IgLON5 disease: A multicenter retrospective study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Papillitis associated with IgLON5 autoimmunity: A novel clinical phenotype;Journal of Neuroimmunology;2024-03

2. Diagnosis and differential diagnosis of MND/ALS: IFCN handbook chapter;Clinical Neurophysiology Practice;2024